TGF-β in diabetic kidney disease: role of novel signaling pathways
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 11 (1-2), 115-123
- https://doi.org/10.1016/s1359-6101(99)00035-0
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- Transforming Growth Factor-β1 Stimulates Protein Kinase A in Mesangial CellsJournal of Biological Chemistry, 1998
- Localization of inositol 1,4,5-trisphosphate receptors in the rat kidneyKidney International, 1998
- Transforming Growth Factor-β1 Inhibits Type I Inositol 1,4,5-Trisphosphate Receptor Expression and Enhances Its Phosphorylation in Mesangial CellsJournal of Biological Chemistry, 1997
- The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent MechanismCell, 1997
- The inositol triphosphate receptor familyCellular Signalling, 1996
- Transforming Growth Factor-β1 Expression and Phenotypic Modulation in the Kidney of Hypertensive RatsHypertension, 1995
- Growth Arrest of a Murine Mesangial Cell Line by Transforming Growth Factor β1 Is Associated with Inhibition of Mitogen-Induced Ca2+ MobilizationBiochemical and Biophysical Research Communications, 1995
- Transforming growth factor β1 modulates angiotensin induced calcium influx in vascular smooth muscleEuropean Journal of Clinical Investigation, 1995
- Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreasDiabetes, 1993